Otolaryngology Doctors in Warner Robins, GA Accepting Medicare

4 Otolaryngology doctors found. Showing 1 - 4

Ronald W Williams Jr., MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 233 N Houston Rd Ste 171, Warner Robins, GA 31093 Phone: 478-352-7050    Fax: 478-352-7069

Alain Daniel Toland, D.O Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1719 Russell Pkwy, Bldg 300, Suite 301, Warner Robins, GA 31088 Phone: 478-923-0106    Fax: 478-922-5211

Zhong Zheng, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 233 N Houston Rd Ste 171, Warner Robins, GA 31093 Phone: 478-352-7050    Fax: 478-352-7069

Kenneth James Walker, MD Otolaryngology Medicare: May Accept Medicare Assignments Practice Location: 300 S Houston Lake Rd, Warner Robins, GA 31088 Phone: 478-971-2500    Fax: 478-971-2503

News Archive

Newly discovered mutation can hold the key to treat a large number of different cancers

Scientists have discovered a mutation responsible for cancer progression, a finding with potential implications for the development of treatment against not one, but a series of cancer types since this mutation can be linked to an abnormality recently discovered to exist in all malignancies.

Genocea Biosciences acquires global license for novel Streptococcus pneumoniae antigens from Children's Hospital Boston

Genocea Biosciences, a vaccine discovery and development company, today announced an exclusive worldwide license for developed countries to a portfolio of Streptococcus pneumoniae antigens from Children's Hospital Boston. PATH and Genocea retain certain co-exclusive rights to the antigens for use in developing countries under their collaboration agreements with Children's Hospital Boston.

State roundup: Cuomo's N.Y. home health reform spurs complaints

Gov. Andrew Cuomo's effort to overhaul New York state's $6 billion home health-care industry is coming under scrutiny from patient advocates and other industry players who say the administration is bowing to the interests of large, politically connected providers.

RXi third quarter net loss increases to $4.1 million

RXi Pharmaceuticals Corporation, a recognized leader in RNAi-based therapeutic discovery and development, today reported its financial results for the third quarter ended September 30, 2010.

Read more Medical News

› Verified 2 days ago